Monday, November 07, 2016 11:12:58 AM
TLLT is currently sitting @ .42, however, based on it's potential, one would think SMFI should surpass TLLT in pps before too long as the story is just starting to unfold here.
It's very hard to put any pps predictions on this. We know they won't be generating any revenue until the R&D period is over but based on the potential and current share structure it should still go pretty far IMO. The patents themselves should have significant value as well, though it will be hard to put a price on them.
Also the research and development of the Gandy Technique has already been on going for 16 years, it's basically been perfected best I can tell from whats publicly available. They are probably not that far off from a human trial, which will most likely take place in Ecuador.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM